CIPO Patents = 2

EPO Patents = 5

Trademarks = 9

Forward Citations = 51

Loading Chart...

11 inventors (with patents filed for the assignee):

Robert Chow (3 out of 3 patents)

Dongming Sun (2 out of 5 patents)

Wise Young (2 out of 7 patents)

4. Robert Fleischaker (2 out of 2 patents)

5. Kam Sze Kent Tsang (2 out of 2 patents)

6. Shinn-Zong Lin (1 out of 37 patents)

7. Woei-Cherng Shyu (1 out of 21 patents)

8. Hung Li (1 out of 19 patents)

9. Richard Tonai (1 out of 1 patent)

10. Rubio R Punzalan (2 patents)

11. Jonas Wang (0 patent)

12. Monica Chen (0 patent)

13. Lawrence D Petz (0 patent)

14. Denis O Rodgerson (0 patent)

15. Kam Sze Tsang (0 patent)

6 patents: Sort by Forward Citations

1. 11318170 - Treatment of brain damage using umbilical cord blood cells (2022-05-03),

2. 10400212 - Stem cell packaging and shipping (2019-09-03),

3. 9951309 - Stem cell packaging and shipping (2018-04-24),

4. 8062837 - Plasma-depleted, not erythrocyte-depleted, cord blood compositions and method of making (2011-11-22),

5. 8048619 - Method of treating a hematopoietic associated disease or disorder with plasma-depleted, but not erythrocyte-depleted cord blood compositions (2011-11-01),

6. 6670124 - High throughput methods of HLA typing (2003-12-30),

Stemcyte, Inc. is a global umbilical cord blood and adult stem cell therapeutic company. Stemcyte is dedicated to advancing the field of stem cell therapy by providing banks of high-quality, ethnically diverse umbilical cord blood stem cells and adult stem cells for transplantation. Their mission is to help save lives and improve health outcomes for patients worldwide.

Profile summary based on public USPTO records.